Cristina Lupo

Cristina Lupo

Auto-generated profile, based on publicly available information

Cristina Lupo

Department of Regenerative Medicine, Houston Methodist Research Institute, Houston, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2014 in Interface Focus
Verified
Journal Article
Open access
PDF file
Laura RussoLaura Russo
Laura Russo
FTFrancesca Taraballi
Francesca Taraballi
CLCristina Lupo
Cristina Lupo
APAna Poveda
Ana Poveda
Jesus Jimenez-BarberoJesus Jimenez-Barbero
Jesus Jimenez-Barbero
LCLaura Cipolla
Laura Cipolla
Different methods for the functionalization of carbonate hydroxyapatite granules with free amine groups by reaction with (3-aminopropyl)triethoxysilane (APTES) have been compared in order to improve the potential for tethering of bioactive molecules to bioceramics. The combined use of tetraethoxyorthosilicate and APTES with acid catalysis resulted in an evident increase in amine surface grafting.

1 March 2013 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
FTFrancesca Taraballi
Francesca Taraballi
SZS. Zanini
S. Zanini
CLC. Lupo
C. Lupo
PSPanseri Sara
Panseri Sara
CCCarla Cunha
Carla Cunha
LCL. Cipolla
L. Cipolla

2 February 2017 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
LPL. Pandolfi
L. Pandolfi
NFN. Toledano Furman
N. Toledano Furman
Xin WangXin Wang
Xin Wang
CLC. Lupo
C. Lupo
JMJ. O. Martinez
J. O. Martinez
ETE. Tasciotti
E. Tasciotti

1 August 2012 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
LGLuca Gabrielli
Luca Gabrielli
ACAlice Capitoli
Alice Capitoli
DBDavide Bini
Davide Bini
FTFrancesca Taraballi
Francesca Taraballi
CLCristina Lupo
Cristina Lupo
LCLaura Cipolla
Laura Cipolla
Abstract: Lipopolysaccharides (LPSs), which constitute the lipid portion of the outer leaflet of Gram-negative bacteria, are essential for growth, and are responsible for a variety of biological effects associated with Gram-negative sepsis. LPSs are amphiphilic molecules comprising three regions: lipid A, the core region, and a polysaccharide portion; the lipid A was proven to represent the toxic principle of endotoxic active lipopolysaccharides. In addition, it is known that the minimal conserved structure of LPS is the lipophylic oligoasaccharidic structure containing Kdo residues linked to the-LipA moiety. Thus, the design and development of novel antibacterial drugs can focus on different aspects, related to the biosynthesis and chemical features of LPS: 1) Inhibitors of lipid A biosynthesis 2) Inhibitors of Kdo biosynthesis. Both Kdo and Lipid A are needed for the construction of the minimum structural element Kdo2-LipidA, needed for bacterial survival. Any inhibitors acting on the biogenetic pathway of this molecule can act as antibacterial. 3) Antagonists of the interaction between endotoxins and the host receptors: LPS is recognised by the CD14 and the Toll-like receptor (TLR)- 4/MD2 complex, where Lipid A is the crucial moiety in the interaction. Any drug acting as an antagonist of this process can have antisepsis potential. Considerable efforts have been made in this direction to identify natural or synthetic molecules able to interfere with the interaction between LPS and inflammatory cells. This review will highlight recent efforts in the design and biological activity of enzyme inhibitors and antagonist acting on the 3 key aspects outlined above.

23 August 2012 in Carbohydrate Chemistry
Verified
Book Chapter
Closed access
PDF file
LCLaura Cipolla
Laura Cipolla
Laura RussoLaura Russo
Laura Russo
FTFrancesca Taraballi
Francesca Taraballi
CLCristina Lupo
Cristina Lupo
DBDavide Bini
Davide Bini
Francesco NicotraFrancesco Nicotra
Francesco Nicotra
Examples of material functionalisation (“biodecoration”) with signalling and relevant glycidic scaffolds will be outlined. Recent research concerning the development of smart biomaterials for Tissue Engineering (TE) applications will be considered.